Meyka Pro banner
Babylon Holdings Limited

Stay Updated with the Latest Babylon Holdings Limited BBLN News in Real Time

Find BBLN news now at Meyka AI. Stay informed with the latest Babylon Holdings Limited stocks updates, including price news, market analysis, and expert insights.

BBLNNYSE
HealthcareMedical - Healthcare Information Services
$0.55
$0.09(13.99%)
U.S. Market opens in 14h 2m
Yash’s Toxic Hits Rs 140 Crore Gross on Day 1, Then Loses Steam on Day 2
📅 in about 3 hours

Yash’s Toxic Hits Rs 140 Crore Gross on Day 1, Then Loses Steam on Day 2

Yash’s Toxic opens with Rs 101.10 crore net on Day 1, one of India’s biggest openers, but drops 84% on Day 2 to Rs 16.48 crore as mixed reviews and trolls emerge.

Read more 12
Hyperliquid Surges 3.2% to $85.08 as Tokenized Stocks Launch Drives Volume
📅 in about 2 hours

Hyperliquid Surges 3.2% to $85.08 as Tokenized Stocks Launch Drives Volume

HYPEUSD rallied 3.2% to $85.08 on August 27 following Hyperliquid’s launch of tokenized stocks and AQAv2 buyback engine on August 26.

Read more 12
Malaysia’s Ex-PM Ismail Sabri Charged With Concealing $40M in Assets on August 27
📅 2 hours ago

Malaysia’s Ex-PM Ismail Sabri Charged With Concealing $40M in Assets on August 27

Ismail Sabri Yaakob, Malaysia’s shortest-serving PM, charged with concealing US$40M in undeclared assets including foreign currencies and gold bars. Faces up to 5 years prison if convicted.

Read more 12
AstraZeneca (AZN) and Amgen’s Tezspire Succeeds in Late-Stage Oesophagus Disease Trial
📅 6 hours ago

AstraZeneca (AZN) and Amgen’s Tezspire Succeeds in Late-Stage Oesophagus Disease Trial

AstraZeneca said Thursday its drug Tezspire met all primary and secondary goals in a late-stage trial. The Phase III CROSSING trial tested Tezspire against placebo in eosinophilic oesophagitis (EoE). AstraZeneca developed the drug jointly with Amgen for this chronic inflammatory oesophagus condition. What the CROSSING Trial Showed The Phase III CROSSING trial evaluated two once-every-four-week…

Read more 12
Shein Sets Hong Kong IPO Price at HK$48.56, Valuing Fast-Fashion Giant at $26.5 Billion
📅 6 hours ago

Shein Sets Hong Kong IPO Price at HK$48.56, Valuing Fast-Fashion Giant at $26.5 Billion

Shein will price its Hong Kong IPO at HK$48.56 per share, people familiar with the matter said Thursday. The price sits near the midpoint of its HK$47.60 to HK$49.50 marketed range. The deal values Shein at roughly $26.5 billion, confirming weeks of investor pushback on valuation. Final Pricing Details Shein’s pricing will raise approximately HK$13.6…

Read more 12
Nvidia Beats Q2 Targets With $96.2B Revenue, Stock Falls 1.6% on August 27
📅 6 hours ago

Nvidia Beats Q2 Targets With $96.2B Revenue, Stock Falls 1.6% on August 27

Nvidia beat Q2 earnings with $96.2B revenue and $2.22 adjusted EPS, but stock fell 1.6%. Q3 guidance of $108B signals strong AI chip demand ahead.

Read more 12
NVDA Stock in Focus as Nvidia Forecasts Strong AI Chip Demand Through Fiscal 2028
📅 8 hours ago

NVDA Stock in Focus as Nvidia Forecasts Strong AI Chip Demand Through Fiscal 2028

Nvidia’s latest results have put NVDA stock back in focus as demand for AI chips continues to hold up. On August 26, 2026, Nvidia forecast about 70% revenue growth for fiscal 2028, well above Wall Street’s 44% estimate. The company also reported $96.22 billion in quarterly revenue, with data-centre sales topping $89 billion. Investors are…

Read more 12
Bikaji Foods (BIKAJI) Shares Jump 4% to ₹635.95 After Strategic Bakery Partnership With Thayekunni Khaleel
📅 9 hours ago

Bikaji Foods (BIKAJI) Shares Jump 4% to ₹635.95 After Strategic Bakery Partnership With Thayekunni Khaleel

Bikaji Foods shares jumped as much as 4% to an intraday high of ₹635.95 on August 27, 2026, before settling up 2.28% at ₹624.65. The rally followed a strategic bakery partnership with Thayekunni Khaleel, founder of the Bakemart brand, through subsidiary Bikaji Bakes Private Limited. Bikaji transferred a 30% equity stake in BBPL to Khaleel…

Read more 12
CrowdStrike (CRWD) Stock Jumps 8% Premarket After Q2 Earnings Beat and Raised FY2027 Outlook
📅 9 hours ago

CrowdStrike (CRWD) Stock Jumps 8% Premarket After Q2 Earnings Beat and Raised FY2027 Outlook

CrowdStrike (CRWD) stock is in focus on August 27, 2026, after the cybersecurity company posted better-than-expected fiscal Q2 2027 results. Revenue came in at $1.47 billion, up 26% year over year, while adjusted earnings topped Wall Street estimates. CrowdStrike also raised its FY2027 outlook and reported record net new ARR of $333 million. Shares jumped…

Read more 12

BBLN News FAQ